Stock INTI INHIBITOR THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Inhibitor Therapeutics, Inc.

Equities

INTI

US45720M1053

Market Closed - OTC Markets
Other stock markets
 17:41:59 15/05/2024 BST 		5-day change 1st Jan Change
0.089 USD -35.34% Intraday chart for Inhibitor Therapeutics, Inc. -31.54% -3.26%
03-29 Inhibitor Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Introducing Inhibitor Therapeutics, Inc. Announces Scientific Advisory Board CI

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Introducing Inhibitor Therapeutics, Inc. Announces Scientific Advisory Board
CI
Inhibitor Therapeutics, Inc. Appoints Michelle Yanez as an Independent Director and a Member of the Audit Committee
CI
Inhibitor Therapeutics, Inc. Appoints Ronald E. Osman as Non-Independent Director on the Board
CI
Inhibitor Therapeutics, Inc. Announces Board Changes
CI
Inhibitor Therapeutics, Inc. Announces Retirement of Debra Peattie from the Board of Directors
CI
Inhibitor Therapeutics Appoints Dr. Debra Peattie to its Board of Directors
CI
HedgePath Pharmaceuticals Inc. will Change its Name to Inhibitor Therapeutics Inc
CI
HedgePath Pharmaceuticals, Inc. Announces Resignation of Brendan Magrab as Director
CI
HedgePath Pharmaceuticals, Inc. Announces Board Changes
CI
HedgePath Pharmaceuticals, Inc. Announces Executive Changes
CI
HedgePath Pharmaceuticals, Inc. Announces Management Changes
CI
HedgePath Pharmaceuticals Appoints Three New Board Members
CI
Commonwealth Biotechnologies, Inc. will Change its Name to HedgePath Pharmaceuticals, Inc
CI
Hedgepath Pharmaceuticals, Inc. Announces Management Changes
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. INTI Stock
  4. News Inhibitor Therapeutics, Inc.
  5. Insiders